The number of American cancer deaths from 2017 to 2018 dropped by 2.4%, marking a record single-year drop for the second year in a row. These new stats were published in the American Cancer Society’s (ACS) annual Cancer Facts & Figures report, which also reveals more positive news regarding the long-term direction of cancer death rates.
The ongoing coronavirus pandemic has created a significant setback in the war on cancer. A report from Boston 25 News says the medical community has understandably been focused on research and treatment of COVID-19 since the outbreak began. And that means many potentially lifesaving cancer research projects are on the back burner until COVID is under control.
Writing a “Year in Review” blog feels a little different in 2020. We typically think back fondly on the year that was; remembering the moments that made it so great. For most of us though, “great” might not be the first word that comes to mind when we think of 2020.
A global pandemic gripped the world and brought with it fear, anxiety, uncertainty, and unfortunately, tragedy. While we can’t ignore the reality of 2020, we can still choose to look beyond the surface of it. We can choose to find the positive, the admirable, and the inspirational.
Here are some of the highlights from 2020 at Provision CARES Proton Therapy. As you close out this tumultuous year, perhaps a reminder of the good that still came out of it will help lead you into 2021 with a sense of hope and optimism.
September is Prostate Cancer Awareness Month and it’s common to hear public service announcements reminding men to get a prostate-specific antigen (PSA) test. Afterall, prostate cancer is the second leading cause of cancer death among American men and early detection is the best prevention.
However, recent recommendations from the U.S. Preventive Services Task Force (USPSTF) cast doubt on whether the potential risks associated with PSA screening are worth the reward. Now though, new research suggests those risks may be exaggerated.
The long-term benefits of the PSA test for prostate cancer may outweigh any potential harm according to a recent paper published in the New England Journal of Medicine (NEJM). While current guidelines advise patients and physicians to determine the value of routine PSA screening on a case-by-case basis, researchers suggest that perceptions of PSA tests as ineffective are based on overstated harms and point to evidence showing that screenings can reduce death rates and prevent metastatic disease.
Provision is proud to announce that we have earned national recognition for our Culture of Care. On September 8, 2020, Provision CARES Proton Therapy Nashville was awarded the distinguished 2020 Press Ganey “Guardian of Excellence Award” for exceptional Patient Experience in Outpatient Oncology.
On August 25, 2020, Jason W. eagerly rang the victory bell to mark the completion of his tonsil cancer treatment. In doing so, he became the 500th patient to complete treatment at Provision CARES Proton Therapy Nashville, reminding us all that cancer and cancer treatment do not delay during a global pandemic.
When the COVID-19 pandemic began, life as we knew it came to an abrupt halt. That included routine healthcare visits, as many providers postponed appointments and cancer screening tests that were deemed “non-essential.”
In the United States alone, an estimated 22 million cancer screening tests were disrupted by COVID-19 from April to June 2020. As a result, about 80,000 patients could be at risk for delayed or missed diagnoses.
The IQVIA Institute for Human Data Science recently published these estimates as part of its report on shifts in healthcare demand, delivery and care during the COVID-19 era. In this article, we’ll look at how diagnostic procedures for some of the most common cancers are impacted. We’ll also share some tips to help you move forward with your cancer-related care in a timely and safe manner.
When you mention the word “cancer,” most people think of more common cancers like breast, lung and prostate cancer. However, July is designated as Sarcoma Awareness Month. It’s an opportunity to help raise awareness about a disease that’s often considered the “forgotten cancer.”
Sarcoma is a cancer of the body’s connective tissues. It begins in bone or soft tissues like fat, cartilage or muscle, and can affect both children and adults. Sarcoma Awareness Month raises awareness of a disease that’s relatively rare. This helps advocacy groups, who are often hindered by the fact that many people don’t even know this type of cancer exists. The public’s lack of awareness and understanding of sarcoma makes it much more challenging to secure funding for research and treatment development.
In this article, we’ll help you develop a better understanding of what sarcoma is, why we have Sarcoma Awareness Month, how you can help the cause, and how proton therapy can help treat sarcoma patients.
The Centers for Disease Control and Prevention (CDC) recently announced new guidelines to help you stay safe when visiting your doctor or getting a prescription filled. In this article, we’ll outline some of the most important takeaways to help you stay safe during healthcare-related trips. More specifically, we’ll also share how those tips can be applied for people who are dealing with cancer.
As local governments loosen coronavirus restrictions and more businesses re-open their doors, it’s important for people to continue practicing preventive actions in order to slow the spread of COVID-19. These new guidelines from the CDC are designed to help you make an informed decision on when it’s appropriate to venture out of your home, and how to protect yourself and others when you do decide to go out.
The National Association for Proton Therapy (NAPT) announced it will host its annual National Proton Conference through a virtual experience. The online event, which will take place on July 24, 2020, is a celebration of the organization’s 30-year anniversary of supporting access to proton therapy, one of the world’s most advanced cancer treatments.